Come join us for a deep dive into the Cerner oncology road map, how-to guidance, solution features and industry trends. Get current on Cerner innovations that can help you address current and emerging initiatives and challenges. You can learn how the innovations impact data and workflows for department leaders and end users and engage with session presenters with real-time Q&A via the virtual chat feature.
Feyi Ayodele, MBA - CEO of Cancer IQ; Shareholder, Cancer IQ and Candace Westgate DO MPH FACOG: Myriad Genetics and Grail - consulting fees
The remaining speakers, content managers, and planners from Cerner Corporation do not have any relevant financial interests to disclose.